erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
.
.
.
.
updated: may 18, 2018, 10.36 am ist
.
nav
?41.93
.
.
glenmark pharma launches generic version of asthma drug in denmark
.
.
.
.